DNA/MVA HIV-1/AIDS vaccine elicits long-lived vaccinia virus-specific immunity and confers protection against a lethal monkeypox challenge is a research paper published in Virology (2007). On theSindex it has a DataRank of 0.617. It has been cited 60 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.617
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 1R21AI053488-01
MVA/HIV-48: Potential Dual Vaccine for HIV and Smallpox
National Institutes of Health
Grant: 5P01AI049364-02
Core--Macaque studies
National Institutes of Health
Grant: 5P51RR000165-35
YERKES REGIONAL PRIMATE RESEARCH CENTER
National Institutes of Health
Grant: 5R01AI057029-02
Poxvirus Immunity and DNA/MVA HIV Vaccines
Fields of Study
Keywords
Sustainable Development Goals